Proceedings: The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate.
about
The periodic health examination. Canadian Task Force on the Periodic Health ExaminationTherapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate CancerContemporary hormone therapy with LHRH agonists for prostate cancer: avoiding osteoporosis and fractureHormone naïve prostate cancer: predicting and maximizing response intervalsImportance of Estrogenic Signaling and Its Mediated Receptors in Prostate CancerProspective randomised trial comparing diethylstilboestrol and flutamide in the treatment of hormone relapsed prostate cancerEarly hormonal data from a multicentre phase II trial using transdermal oestrogen patches as first-line hormonal therapy in patients with locally advanced or metastatic prostate cancer.Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.Hormonal therapy for stage D cancer of the prostateTreatment of prostate cancer.Androgen Deprivation Therapy and the Re-emergence of Parenteral Estrogen in Prostate Cancer.Phenotype-specific CpG island methylation events in a murine model of prostate cancer.Adenocarcinoma of the prostate in perspective.Management of Hormone-Sensitive and Hormone-Refractory Metastatic Prostate Cancer.The management of prostate cancer in patients with a rising prostate-specific antigen level.Prostate cancer: 9. Treatment of advanced disease.Androgen deprivation therapy for prostate cancer-review of indications in 2010Hormonal treatment for prostate cancer.Diethylstilboestrol for the treatment of prostate cancer: past, present and future.Endocrine therapy for prostate cancer.Effect of stilboestrol on sodium balance, cardiac state, and renin-angiotensin-aldosterone activity in prostatic carcinoma.The treatment of prostate cancer: an overview of current options.Pharmacotherapy for biochemical recurrences after therapy for localised prostate cancer.Exogenous estrogen effect on lipid/lipoprotein cholesterol in transsexual males.Parenteral oestrogen in the treatment of prostate cancer: a systematic reviewControversies surrounding androgen deprivation for prostate cancer.Gender differences in cardiovascular disease: hormonal and biochemical influences.Molecular Basis of Steroid Action in the Prostate.Hsa-miRNA-765 as a key mediator for inhibiting growth, migration and invasion in fulvestrant-treated prostate cancer.Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancerHormonal therapy in metastatic prostate cancer: current perspectives and controversiesA subcutaneous delivery system for the extended release of leuprolide acetate for the treatment of prostate cancer.Timing and choice of androgen ablation.Simultaneous administration of pure antiandrogens, a combination necessary for the use of luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer.An update on androgen deprivation therapy for prostate cancer.The size of clinical trials in cancer research--what are the current needs? Medical Research Council Cancer Therapy Committee.Immediate versus deferred treatment for early prostatic cancer.Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09).A Randomised Comparison Evaluating Changes in Bone Mineral Density in Advanced Prostate Cancer: Luteinising Hormone-releasing Hormone Agonists Versus Transdermal OestradiolDoes failure of single hormone therapy delineate hormone refractoriness for prostate cancer?
P2860
Q24669804-1B0CE428-AE9C-41C5-94CC-D66193804317Q26750620-DF7277BB-E32A-49E8-9037-7BEABE2167E9Q26801227-D69CD2AF-7FBE-4186-ACED-BA7777A3AFE3Q27015904-84DB3304-6F57-492D-8552-19B7E2A13816Q28077543-2C47E2A1-7AF1-4290-9B37-C9F47274BB49Q28193725-8897BF95-96F4-4F8A-AC3E-C9A9E4E4B937Q31153083-9A4C21C6-8B28-4542-8142-B28E1151AA69Q32064496-C4C3F7AC-C2DC-42AB-A2BC-C3A1C58E1EDFQ33607710-C98A9985-374B-48AA-8F5E-EBFA1775A54CQ33668839-2762ABBE-97AB-4593-AB69-4321E924FB42Q33736308-F60E9EC5-0ACE-4269-9889-9473A5A7DCDCQ33775468-3029CEE4-10FD-4F58-AC2A-616E238654C7Q33783659-DF550077-1C96-41C6-ABE2-7C21645E337EQ33889276-EF86E3E1-7B15-4EA6-A100-125CB8F94A83Q33962011-32C0CE5B-54F2-41F7-A2B3-9B1C413A7DC5Q34030515-892C5EFE-B7AC-4177-BE96-645A22AD3B08Q34111603-B73519E6-7C85-46FE-910C-F88D1A7FCF50Q34167174-019D26F1-2031-4EB6-906D-BA3D22FB05B7Q34386403-DB8654F0-31DA-4E5A-9967-95C6EB84E9CBQ34451239-1B1912F6-747C-47B5-A05A-A5C73723D2A3Q34490249-16E88CB2-E6C7-46DD-9196-144E2C577DBDQ34552438-0749E96D-1152-4F8E-B827-018738E6DB84Q34660732-D20C3A50-AB0C-41FF-8A99-7AEFB6A01EEFQ34680305-E00810DC-2588-48D6-9162-5CAA3CAAE4A3Q34749291-DD2AA824-EB0C-4652-9DD5-A99A17F1107FQ34849222-4434FB3C-B377-430C-8F4E-CAD556A563FFQ35023822-CCDE9CF7-EDD8-4C96-8E0C-14F20888B83BQ35024939-DD12860C-20F6-40B6-B91D-FE02FDBF841FQ35170430-41885FEC-9CBD-4F6B-A0B8-D49BAABB1AFFQ35564460-44FD6AC4-873F-4E43-9FE4-568D36FA117AQ35569303-701638A7-D765-463D-865F-16CAB2887FB4Q35680629-F293A15F-8F3E-421D-905F-85850FF31B0FQ35847645-6305D4BC-AE36-4BA3-B529-94725BD59D89Q36263395-6A4658B2-57AF-484E-B46E-224A5FE32DB9Q36289952-FC083FD2-D8BD-44DB-A065-863F2D097716Q36467361-F8947703-A5A0-428F-BCFD-B509BAFB798AQ36721876-156CF89C-32D3-4E9B-A2C7-75837F90F8FFQ36751550-33BF1AE3-72FF-46A1-9092-5DF3DBEC56D3Q36861650-A0B2797D-F3DF-49AC-82BE-DA424A52E5E9Q36956418-632AD076-208C-4F1D-BA99-D9724D9DC830
P2860
Proceedings: The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate.
description
1973 nî lūn-bûn
@nan
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
1973年论文
@zh
1973年论文
@zh-cn
name
Proceedings: The Veterans Admi ...... ies of cancer of the prostate.
@en
Proceedings: The Veterans Admi ...... ies of cancer of the prostate.
@nl
type
label
Proceedings: The Veterans Admi ...... ies of cancer of the prostate.
@en
Proceedings: The Veterans Admi ...... ies of cancer of the prostate.
@nl
prefLabel
Proceedings: The Veterans Admi ...... ies of cancer of the prostate.
@en
Proceedings: The Veterans Admi ...... ies of cancer of the prostate.
@nl
P1433
P1476
Proceedings: The Veterans Admi ...... ies of cancer of the prostate.
@en
P2093
P304
P356
10.1002/1097-0142(197311)32:5<1126::AID-CNCR2820320518>3.0.CO;2-C
P407
P577
1973-11-01T00:00:00Z